The potential therapy for idiopathic pulmonary fibrosis is notable because not only was the small molecule discovered by ...

Hospital for Special Surgery (HSS) presented a research study at the European Alliance of Associations for Rheumatology ...

Mohammed Sadhik Shaik, a researcher and IT specialist, is addressing this issue through ongoing work on Blockchain and ...

The journey doesn’t end with a diagnosis. AI is helping patients move faster toward new treatments, clinical trials, and ...

There are subtle but significant differences in the morphology and biochemistry of the eye between men and women. These differences may affect disease susceptibility, symptoms and progression, ...

Insulin resistance (IR) is a crucial factor in metabolic disorders like non-alcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS), ...

AI guidance for clinicians aimed at reducing the spread of Clostridioides difficile—a bacteria that can be deadly for sick ...

Friday’s deal with fits neatly within AstraZeneca’s business development strategy of upping investments in AI and in China.

The adoption of AI agents in healthcare is an essential strategy for institutions that seek efficiency, agility and smarter ...

AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...

The technology’s potential to transform trials will need to be balanced with the challenge of instilling trust in participants.

Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...